Mycophenolate mofetil: An open-label study in 42 MS patients

被引：0
|
作者：
Vukusic, S. [1 ]
Ducray, F. [1 ]
Gignoux, L. [1 ]
Durand-Dubief, F. [1 ]
Achiti, I. [1 ]
Blanc, S. [1 ]
Confavreux, C. [1 ]
机构：
[1] Hop Neurol & Neurochirurg P Wertheimer, Dept Neurol A, Lyon, France
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [1] Mycophenolate Mofetil: An open-label study in 42 MS patients
    Vukusic, S
    Ducray, F
    Gignoux, L
    Dubief, FD
    Achiti, I
    Blanc, A
    Confavreux, C
    NEUROLOGY, 2004, 62 (07) : A491 - A491
  • [2] Mycophenolate mofetil: an open-label study in 42 MS patients
    Ducray, F
    Vukusic, S
    Gignoux, L
    Durand-Dubief, F
    Renoux, C
    Achiti, I
    Blanc, S
    Confavreux, C
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S263 - S263
  • [3] Mycophenolate Mofetil for the Treatment of Chronic Dermatitis: An Open-label Study of 16 Patients
    Jackson, J. Mark
    Fowler, Joseph F., Jr.
    Callen, Jeffrey P.
    Lorenz, Douglas J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (04) : 356 - 362
  • [4] Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
    Ciafaloni, E
    Massey, JM
    Tucker-Lipscomb, B
    Sanders, DB
    NEUROLOGY, 2001, 56 (01) : 97 - 99
  • [5] Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy - An open-label study
    Radziwill, A. J.
    Schweikert, K.
    Kuntzer, T.
    Fuhr, P.
    Steck, A. J.
    EUROPEAN NEUROLOGY, 2006, 56 (01) : 37 - 38
  • [6] A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
    Derk, Chris T.
    Grace, Elizabeth
    Shenin, Max
    Naik, Manisha
    Schulz, Steffan
    Xiong, Wen
    RHEUMATOLOGY, 2009, 48 (12) : 1595 - 1599
  • [7] Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
    Sato, Takeo
    Inokuma, Shigeko
    RHEUMATOLOGY, 2010, 49 (08) : 1607 - 1607
  • [8] Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis: reply
    Derk, Chris T.
    Grace, Elizabeth
    Shenin, Max
    Naik, Manisha
    Schulz, Steffan
    Xiong, Wen
    RHEUMATOLOGY, 2010, 49 (08) : 1608 - 1608
  • [9] Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open-label pilot study
    Bishnoi, Anuradha
    Vinay, Keshavamurthy
    Parsad, Davinder
    Kumar, Sheetanshu
    Chatterjee, Debajyoti
    Saikia, Uma Nahar
    Kumaran, Muthu Sendhil
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : 278 - 285
  • [10] An open-label 12-month trial of mycophenolate mofetil in myasthenia gravis
    Gogovska, L.
    Ljapcev, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 273 - 273
12345